ABSTRACT FANCM, the most highly conserved component of the Fanconi Anaemia (FA) pathway can resolve recombination intermediates and remodel synthetic replication forks. However, it is not known if these activities are relevant to how this conserved protein activates the FA pathway and promotes DNA crosslink repair. Here we use chicken DT40 cells to systematically dissect the function of the helicase and nuclease domains of FANCM. Our studies reveal that these domains contribute distinct roles in the tolerance of crosslinker, UV light and camptothecininduced DNA damage. Although the complete helicase domain is critical for crosslink repair, a predicted inactivating mutation of the Walker B box domain has no impact on FA pathway associated functions. However, this mutation does result in elevated sister chromatid exchanges (SCE). Furthermore, our genetic dissection indicates that FANCM functions with the Blm helicase to suppress spontaneous SCE events. Overall our results lead us to reappraise the role of helicase domain associated activities of FANCM with respect to the activation of the FA pathway, crosslink repair and in the resolution of recombination intermediates.
INTRODUCTION
A fundamental defect in DNA repair causes Fanconi Anaemia (FA), a genetic illness that leads to abnormal development, bone marrow failure and cancer. As many as 13 genes are known to be mutated in FA, most of these physically and genetically interact to form the FA genome stability pathway (1, 2) . A key question concerns how such a pathway stimulates DNA repair. The identification of FANCM, a highly conserved gene in the FA pathway, may shed light on this crucial question. Vertebrate FANCM contains highly conserved amino (N) terminal helicase and carboxy (C) terminal nuclease like domains, which suggest that it participates directly in DNA repair (3, 4) . This domain arrangement is identical to that of the archaeabacterial FANCM orthologue Hef, in which the activities of both domains are coordinated to unwind and cleave a replication fork (5) . Recently, FANCM N-terminal helicase and C-terminal nuclease domains have been shown to interact with HCLK2 to promote the activation of DNA damage checkpoints (6) . The C-terminal nuclease domain of FANCM interacts with a 24 kDa protein (FAAP24) and this protein complex binds to synthetic replication fork-like DNA structures, preferentially to ssDNA, splayed-arm, and 3 0 -flap DNA substrates (7) . FAAP24 knock down abolishes DNA damage inducible FANCD2 monoubiquitination and leads to sensitivity to DNA crosslinking agents (7) .
Biochemical studies of vertebrate and yeast FANCM orthologues, FML (S. pombe) and MPH1 (S. cerevisiae), have revealed that these proteins can bind Holliday junctions and replication fork-structured DNA. Yeast and human FANCM orthologues also promote fork regression, Holliday junction migration and can also unwind RPA-stabilized D-loops (8) (9) (10) (11) . Furthermore, genetic studies performed in yeast show that the FANCM orthologues promote replication restart and suppress crossovers following sister chromatid recombination after DNA damage (9, 12) . It is important to emphasize here that only translocase but not helicase activity has been reported for the full length purified FANCM. In addition close sequence analysis of the nuclease like domain does suggest that key catalytic residues seem to be missing leading to the conclusion that this region does not confer nuclease activity. Nevertheless taken together, these findings have led to the proposal that FANCM may move along double-stranded DNA, sensing, remodelling and restarting stalled replication forks.
While some progress has been achieved towards defining the biochemical functions of FANCM in different organisms, evidence about how these activities promote DNA repair following DNA damage in vivo is limited. The yeast orthologues, FML and MPH1, contain only the N terminal helicase-like domain and lack both the middle and C-terminal sections found in vertebrate FANCM. Additionally, no other FA genes have been identified in yeast to date. Therefore, it has not been possible to extrapolate the function of FANCM in the FA DNA repair pathway from the reported in vivo activities of yeast FANCM orthologues.
To circumvent the difficulties encountered in expressing transfected FANCM in either human or chicken FANCM deficient cell lines, Wang and colleagues have used a transient siRNA approach to knock down endogenous FANCM expression in a human cell line. This cell line was simultaneously complemented with siRNA resistant FANCM cDNA. Using this approach they showed that HeLa cells harbouring a point mutation in the ATPase Walker A sequence of FANCM were defective in crosslink repair despite being competent in FANCD2 monoubiquitination (13) . This result therefore strongly suggests that the translocase activity of FANCM imparts crosslink repair function.
This work addresses the functions of the distinct domains of chicken FANCM in DNA repair. We systematically dissect how different domains of this large protein function to activate the FA pathway and promote DNA crosslink repair. Furthermore, our genetic analyses uncover two new functions of FANCM that do not overlap with its role in the FA pathway: UV and camptothecin induced DNA damage tolerance. Finally we discover a role for FANCM in the suppression of crossover recombination with the Bloom's (BLM) helicase.
METHODS

Gene disruption of the chicken FANCM locus
The chicken FANCM locus was identified by BLAST search using the human protein sequence against the ENSEMBL draft chicken genome sequence. An ENSEMBL predicted transcript encompassed most of the FANCM gene, although the 5 0 end, containing some of the helicase motifs, was missing. The complete 5 0 end of the gene was amplified by PCR and all exons encoding the Mph1 like domain were identified. Sequence from the predicted and PCR amplified genomic DNA was used to design the two gene disruption cassettes (A and B). PCR oligos used to amplify 5 0 and 3 0 arms of construct A were TCGTGACACTTAATCCCTCGGTGCTCTGAGC/GA AGGGCGACAAAACCAACTTCCC and AGGCTGTG CAGCAGGTTGTTTCCAA/TGCAACACACAGCGT GACACCCAGT, respectively. Those for the knockin construct B were 5 0 arm: AGCGGCGCTGGTCTATAT CTTTAGGG/GCAGACAGCGCTGAGGGGAATACA and 3 0 arm ACCAAAAGCTGATGGACATCCAAAT CC/AGTTGCCATAGGAAATGATGTTGGTGTCAG. PCR products were cloned into pCR2.1-TOPO (Invitrogen) and then the D203A point mutation was introduced using Stratagene QuickChange XL site directed mutagenesis kit and the following primers: GTTAAA TGCTTGGTTGTTGCCGCGGCCCACAAAGCTCTG GG/CCCAGAGCTTTGTGGGCTTCGGCAACAACC AAGCATTTAAC. Transfections, selection and Southern analyses of targeted DT40 clones were carried out as described previously (4, 14) . The lox drug resistance cassette was removed by transiently transfecting cell lines with the Cre recombinase NLS-expression plasmid. Cells were cloned by limiting dilution and then tested individually for loss of drug resistance. To confirm the appropriate disruptions of the GgFANCM locus the following PCR oligos were used; F1, TTTGGGACGGGAATAGA GC; R1, GCCACCTCCTTTCCTCTAT. Generation of ÁBLM FANCM-D203A knockin cell line was carried out by targeting sequentially FANCM-D203A Knockin and FANCM-hel constructs into the ÁBLM strain [kind gift from Professor Enomoto (19) ]. 5 0 and 3 0 arms of the FANCC in situ TAP-tagged construct were generated as described before (4) .
Flag-tag constructs were amplified using chicken FANCM cDNA using forward primers CCGAGATCT CACCATGGATTACAAGGATGACGACGATAAGG ACTATAAGGACGATGATGACAAGAGCGGCGGC CGGCAGCGCACCCTGCCC for the +HEL construct and CCGGGATCCCACCATGGATTACAAGGATGA CGACGATAAGGACTATAAGGACGATGATGACA AG GGGGATTGCAGCTATGAACTGGAGCTT for either +LMS or +NUC constructs and reverse primers CCGAGATCTTCCTTCAGCAGGAAACACACGTGA G for the +HEL construct, CCGGGATCCTCCTTCAG CAGGAAACACACGTGAG for the +LMS construct and CCGGGATCCAGCGGCCGCTCAGCTCCTGC TG for the +NUC construct. These PCR products were cloned into pCR-TOPO and verified by sequencing. These fragments were cloned from pCR-TOPO into the expression plasmid pEXPRESS and checked for orientation. Expression cassettes were cloned into drug resistance cassette-containing pLOX plasmids. Proteins expression was confirmed by western blot.
Mutagen sensitivity assays
For cisplatin survival assays cell lines were plated into 96-well plates at a density of 3000 cells per plate. A range of doses of cisplatin was added to wells, and the plates were returned to the incubator for five complete cell-doubling times. After this the cells were pulsed with MTS (Promega) and incubated for another 1 h. Cell viability was measured by luminometry according to manufacturer's instructions (Promega), and each dose point was assayed in triplicate. The colony survival values plotted are relative to an untreated control.
For UV sensitivity, cells were irradiated with the indicated doses, diluted in medium and grown for 2 weeks in methylcellulose containing plates. For camptothecin sensitivity, cells were grown for 2 weeks in CPT-containing methylcellulose plates. Plots represent the average of three independent experiments. Error bars represent standard deviation.
FANCC-TAP precipitation
Treated or untreated cells (10 9 ) were lysed in lysis buffer (50 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.1% Triton X-100, 200 mM NaCl and protease inhibitor cocktail (Roche Molecular Biochemicals)) with a Dounce homogenizer. Lysates were cleared by centrifugation using a Beckman rotor Ti45, at 48C and 35 000 r.p.m. for 60 min. Extracts (9 mg total protein) were incubated for 2 h at 48C with 50 ml IgG-Sepharose beads (Amersham). Precipitated material was extensively washed with lysis buffer containing 500 mM NaCl. Precipitated material was resolved by 4-12% Bis/Tris-SDS-PAGE (Invitrogen) and detected by immunoblot with antibodies to Flag, GgFANCG, or TAP. Western blot analyses for FANCD2 were done as described previously (14) . Detection of chicken FANCM was carried out using antisera directed to the large middle section of the chicken FANCM gene. The details of this reagent are published in Mosedale et al. (4) .
Cellular subfractionation
Two hundred million DT40 cells were treated with 1 mM cisplatin for 16 h, harvested, washed once with PBS and lysed in hypotonic buffer (10 mM Tris-HCl pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 , 10 mM 2-mercaptoethanol) by pushing cells through a 19G needle. Nuclei were collected by centrifugation (2700 g, 10 s) washed twice with hypotonic buffer and nuclear proteins were extracted with a high-salt buffer (15 mM Tris-HCl, pH 7.4, 1 mM EDTA, 500 mM NaCl, 1 mM MgCl 2 , 10% glycerol, 10 mM 2-mercaptoethanol and protease inhibitor cocktail). To enrich for chromatin-associated proteins, salt-extracted pellets were treated with 1500 units micrococcal nuclease (Amersham) for 20 min at room temperature in nuclease reaction buffer (20 mM Tris-HCl, pH 7.4, 100 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 0.3 M sucrose, 0.1% Triton X-100 and protease inhibitor cocktail). Comparable amounts (relative to each fraction) were resolved on 4-16% Trisglycine gels (Invitrogen) by SDS-PAGE and analysed by immunoblotting using anti-FLAG (sigma), anti PAP or anti-histone H3 (Abcam) antibodies.
Gel-filtration analyses
High salt nuclear extracts were prepared with a few modifications as described previously (4) . Briefly, proteins were extracted from nuclei (isolated from 4 Â 10 9 DT40 cells as indicated) with nuclear extraction buffer [15 mM Tris-HCl, pH 8.0, 0.2 mM EDTA, 420 mM NaCl, 1.5 mM MgCl 2 , 25% glycerol, 0.5 mM DTT and protease inhibitor cocktail (Roche Molecular Biochemicals)]. Cleared nuclear extracts (3.5 mg) were directly applied to a Superose 6 HR16/50 column (Amersham) equilibriated with column buffer (15 mM Tris-HCl pH, 8.0, 0.2 mM EDTA, 420 mM NaCl, 1.5 mM MgCl 2 , 10% glycerol, 0.5 mM DTT). Fractions (4 ml) were collected and aliquots were resolved by 4-12% Bis/Tris-SDS-PAGE (Invitrogen). FANCC-TAP was detected by immunoblot analyses with an antibody to TAP (Sigma). FANCM and FANCG were detected by immunoblot analyses with antibodies raised against GgFANCM and GgFANCG, respectively. The Superose 6 column was calibrated with a high molecular weight calibration kit (Amersham).
SCE analysis in DT40 cells
We carried out SCE assays as previously described (14) using 10 mM BrdU for two cell cycles and adding 0.1 mg (per ml) of colcemid 2.5 h before harvesting cells. The slides were coded (therefore blinded to the observer) and approximately 50 metaphases for each cell line were scored.
RESULTS
Hypomorphic alleles of FANCM in DT40 show different phenotypes
As a first step to distinguish between the functions of the distinct domains of FANCM, we disrupted the exons encoding either the helicase (FANCM-Áhel) ( Figure 1A ) or the nuclease domain (FANCM-Ánuc) (Mosedale 2004 ). DT40 strains carrying homozygous deletion of either of these domains were then compared to the fulllength deleted FANCM (ÁFANCM) strain in terms of FANCD2 monoubiquitination and sensitivity to DNA crosslinking agents ( Figure 1B and C). When these cell lines were exposed to high doses of cisplatin, we noted that FANCD2 ubiquitination in the FANCM null cell line was defective compared to wild-type, but importantly was clearly detectable. However, deletion of FANCL a member of FA core complex, completely abolished FANCD2 monoubiquitination. In the FANCM-Áhel cell line, FANCD2 monoubiquitination levels were also diminished, but were unperturbed in the FANCM-Ánuc cell line. We also measured the sensitivity to cisplatin of the FANCM deficient cell lines. The FANCM null cell line was more sensitive to cisplatin than FANCM-Áhel, whilst FANCM-Ánuc is not sensitive to this agent ( Figure 1C ). This sensitivity partially correlates with the ability of these cell lines to monoubiquitinate FANCD2. A feature of all chicken DT40 FA pathway knockouts is the presence of raised spontaneous sister chromatid exchange events (SCEs) (14) (15) (16) (17) . FANCM deficient DT40 cells display increased numbers of spontaneous sister chromatid exchanges (SCEs) (4). We therefore compared the levels of SCEs in each FANCM mutant strain. The ÁFANCM (mean = 9.0 SCEs per metaphase) and the FANCM-Áhel (mean = 9.2 SCEs per metaphase) strains show elevated SCEs, whilst FANCM-Ánuc (mean = 1.3 SCEs per metaphase) shows wild-type SCEs levels ( Figure 1D ). Double mutants of genes involved in the FA repair pathway such as FANCC/FANCG, FANCC/FANCA and FANCC/ FANCJ do not lead to an increase in SCEs compared to respective single mutants, indicating that SCEs arise by virtue of a common process (14, 16) . As FANCM is a component of the FA core complex, we compared SCEs levels in the double mutant cell line ÁFANCM ÁFANCC and the respective single mutant strains. Strikingly, the double ÁFANCM ÁFANCC strain (mean = 14.9 SCEs per metaphase) has more spontaneous SCEs than either single knockout strain, indicative of an additive impact on this phenotype. Cumulatively, these results suggest that the helicase but not the nuclease domain of FANCM is required for crosslink repair and SCE suppression.
Complementation of the FANCM knockout with FANCM domain-specific cDNA
Immunoblot analyses failed to detect residual FANCM protein in any of these strains indicating that the respective disruptions did result in reduced protein expression. However, since the phenotypes of FANCM-Áhel and FANCM-Ánuc cells clearly differed we believe that this most likely reflects the creation of hypomorphic alleles of FANCM (data not shown). To confirm this, we generated FANCM Flag-tagged domain specific over-expression constructs (Figure 2A ). These constructs consist of the helicase domain with the large middle section (LMS) of FANCM (+HEL construct), the LMS alone (+LMS construct), or the LMS with the nuclease domain (+NUC construct). LMS was included in all constructs since this region contains the putative bipartite nuclear localization signal. To monitor the FA core complex dynamics, we expressed these cDNAs in a ÁFANCM strain that carries a FANCC-TAP tagged allele (ÁFANCM FANCC-TAP).
Drug resistant clones were then tested for expression and complementation of the various ÁFANCM associated defects, such as DNA damage induced FANCD2 monoubiquitination ( Figure 2B ), cisplatin sensitivity ( Figure 2C ), ability to interact with the FA core complex ( Figure 2D ), chromatin targeting of the core complex ( Figure 2E ) and finally SCEs ( Figure 2F ). The construct containing the helicase domain (+HEL) partially rescues the FANCD2 monoubiquitination defects ( Figure 2B , compare 18.9 monoubiquitination induction fold in +HEL cell line to 12.2 shown by ÁFANCM cell line) and cisplatin sensitivity seen in ÁFANCM cell line ( Figure 2C ), it is able to form a stable FA core complex and facilitates accumulation of this complex on chromatin ( Figure 2D and E) . Moreover, the FANCM helicase domain also partially suppresses elevated SCEs in the FANCM null mutant ( Figure 2F ). The construct containing the nuclease domain of FANCM partially rescues the FANCD2 monoubiquitination defect observed in ÁFANCM ( Figure 2B , +NUC cell line shows 28.1 monoubiquitination induction fold compared to 12.2 shown by ÁFANCM cell line) indicating that this function is redundant to the helicase domain. It can also assemble into the FA core complex ( Figure 2D ), however it does not rescue cisplatin sensitivity or the elevated levels of SCE detected in ÁFANCM (Figure 2C and F) . Finally, +LMS does not complement any of the defects observed in FANCM null cell line but importantly, it can interact with the FA core complex ( Figure 2D ). These results indicate that the helicase and nuclease domains play redundant roles in FANCD2 ubiquitination process, however, only the helicase domain partially rescues ÁFANCM cells from sensitivity to cisplatin and to suppress elevated levels of SCEs observed in the FANCM null cell line. As all the constructs can interact with the FA core complex, we also conclude that LMS region is required to anchor FANCM into this complex. In the course of our studies of the ÁFANCM strain we noticed that this mutant was also sensitive to UV light and camptothecin (CPT). This is not a feature shared with any of the other FA gene knockouts (data not shown). We decided to investigate this further by identifying the section of FANCM that may be important for either UV light or CPT tolerance. As can be seen in Figure 3A , the ÁFANCM strain is sensitive to UV light (D 10 value -WT = 5.1 J/m 2 ÁFANCM = 2.8 J/m 2 ). However, this sensitivity can be complemented with the construct containing the helicase domain (D 10 value-+ HEL = 4.7 J/ m 2 ) ( Figure 3B ). A similar analysis was also carried out for CPT sensitivity. Again we noted that ÁFANCM is sensitive to this agent ( Figure 3C ). CPT sensitivity, in contrast to UV sensitivity, is partially complemented by the construct containing the nuclease domain but not by the helicase domain ( Figure 3D ). Cumulatively, the results indicate that the region encompassing the helicase domain of FANCM promotes repair of UV light damage, whilst that encompassing the nuclease domain appears to be critical.
A point mutation in the helicase Walker B motif separates SCE suppression from crosslink repair functions of FANCM We then focused our studies on the raised spontaneous SCEs in the ÁFANCM and ÁFANCM-hel strains. Genetic epistasis results indicate that these raised spontaneous SCEs are not simply due to a defective FA pathway ( Figure 1D ). To determine whether the putative helicase activity of FANCM suppresses SCEs, an inactivating point mutation (DEAD to AEAD) was introduced into the Walker B motif of this domain. The isolated strain, FANCM-D203A (helicase domain disruption in one allele and knockin into the second allele), contains the relevant mutation in the genomic sequence (Supplementary Figure 1) and importantly expresses full length FANCM protein ( Figure 4A ). To our surprise, we noted that the point mutant strain was proficient in monoubiquitinating FANCD2 ( Figure 4A ) and not sensitive to cisplatin ( Figure 4B ) indicating that the Walker B motif is dispensable for crosslink repair. Next we knocked in a TAP tag into the last exon of the FANCC allele. This results in the expression of endogenously TAP tagged FANCC which enables us to determine the stability of the FA core complex in our point mutant cell line ( Figure 4C ). In WT cells, the FA core complex migrated in a peak corresponding to 1 MDa. In ÁFANCM and FANCM-Áhel cell lines, this complex eluted at a lower molecular weight when compared to the wild type. However, the gel filtration profile for the FANCM-D203A cell line was identical to the wild type profile, indicating that the FA core complex is intact ( Figure 4C) . Strikingly, this mutant shows high levels of SCEs ( Figure 4D ) demonstrating that the suppression of SCEs can be attributed to the enzymatic activity of the helicase domain of FANCM. Therefore, the Walker B box mutation D203A dissociates the role of FANCM in crosslink repair and FANCD2 monoubiquitination from that in suppressing SCEs. Since FANCM and both yeast FANCM orthologues also suppress crossover recombination (9) , this indicates that the SCEs suppression function of FANCM is conserved in evolution.
FANCM functions with the Bloom helicase to suppress SCEs
The Blm helicase is the main guardian against SCEs in eukaryotes (18). The yeast FANCM orthologues function in a distinct SCE suppression pathway to their respective Blm orthologues (9) . In order to test whether vertebrate FANCM functions in the same or a distinct SCE suppression pathway to Blm, we made the helicase point mutation D203A in a DT40 BLM knockout cell line (ÁBlm) (19) to obtain the cell line ÁBlm FANCM-D203A (Supplementary Figure 2) . The double mutant strain displayed the same viability as the single ÁBlm strain (Supplementary Figure 2) . This strain was proficient at FANCD2 monoubiquitination although with slightly reduced efficiency when compared to either single mutant strain ( Figure 5A ). We also determined the crosslink sensitivity and particularly noted that the ÁBlm FANCM-D203A strain retained the cisplatin sensitivity of the ÁBlm strain ( Figure 5B ). Most importantly, the number of SCEs in the ÁBlm FANCM-D203A strain (mean = 15.2 SCEs per metaphase) was equivalent to the ÁBlm strain (mean = 14 SCEs per metaphase) ( Figure 5C ). Since FANCM functions within the FA core complex and also with Blm to carry out distinct functions, we set out to determine if the distribution of FANCM protein complex(es) is/are altered in the absence of Blm or the FA core complex. Nuclear extracts from wild-type, ÁBlm and ÁFANCL DT40 strains were fractionated by size exclusion chromatography and blotted for FANCM or the FA core complex protein FANCG. The high molecular mass FANCM complex is unperturbed in ÁBlm cells but shifts to a slightly smaller mass when the FA complex integrity is disrupted, as seen in ÁFANCL cells ( Figure 5D ). In addition, FANCM is stable and it can be phosphorylated in most chicken FA knockout cell lines ( Figure 5E ). Together, these studies point to the existence of a distinct stable FANCM complex that does not contain BLM or the FA core complex. Cumulatively, these experiments indicate that FANCM contributes only in a subset of Blm suppressible SCE events.
DISCUSSION
In conclusion our systematic genetic dissection of chicken FANCM reveals how this protein promotes activation of the FA pathway and crosslink repair. In addition we discovered that FANCM is not only required for tolerance of UV and camptothecin induced DNA damage, but also for the suppression of crossover recombination.
Monoubiquitination of FANCD2 is crucial for the activation of the FA pathway. This process requires an intact FA core complex, Ube2t and FANCI, occurring only during the S and G2 phases of the cell cycle (20) . The core enzymatic basis of this reaction is probably modulated by the E2 ligase (Ube2t) interacting with the E3 (FANCL embedded in the core complex) and the substrate (FANCD2 complexed to FANCI) (21) (22) (23) . Studies using siRNA knockdown of FANCM or its nuclease domain binding partner FAAP24 in human cell lines show that FANCD2 monoubiquitination is severely impaired. In contrast, although chicken FANCM knockouts have reduced FANCD2 monoubiquitination, the defect in this modification is less marked than that observed in human cell lines. Moreover, when the ÁFANCM strain is exposed to large doses of cisplatin we can still see DNA damage induced FANCD2 monoubiquitination. Despite this discrepancy, a question that remains is how FANCM stimulates DNA damage inducible FANCD2 monoubiquitination. This cannot simply be due to assembly of the residual FA core complex existing in the ÁFANCM strain. One possibility is that FANCM mobilizes the FA core complex to chromatin by recognizing damaged DNA replication forks (4, 24) . Indeed both the helicase and nuclease domains can bind fork structured DNA (4, 7, 8) and we show here that both domains can independently stimulate FANCD2 monoubiquitination. However if stalled replication forks degenerate into double strand breaks in FANCM null cells, then this may enable a residual FANCM deficient core complex to stimulate FANCD2 monoubiquitination.
A key function of the FA pathway is to promote DNA crosslink repair. Genetic studies indicate that the FA proteins work upstream of a combined HR and TLS process to remove crosslinks (14) . A recent report using Xenopus extract provides biochemical proof of such a combined process (25) . We currently do not know the molecular basis of the putative upstream role of the FA pathway in such a combined process. However, FANCM clearly plays a key role in this process and it may now be possible using the genetic and biochemical evidence to integrate this into a working model. Our study clearly shows that the N-terminal helicase domain is crucial for effective repair, although a predicted inactivating mutation in the helicase domain has no impact on crosslink repair. The biochemical activities of FANCM, such as branch migration, translocase activity, D-loop dissolution and fork regression, all require ATPase activity and are very likely to be significantly impacted by mutation of the DEAD box. This suggests that these activities may not confer crosslink repair activity to FANCM. On the other hand, the siRNA complementation based approach does suggest that ATP binding is required for crosslink repair (13) . It is therefore plausible that the ATP binding in the context of an intact helicase domain is crucial for crosslink repair, although this may not simply be used to drive the helicase or translocase functions. We propose that the helicase domain of FANCM recognizes and binds to stalled replication forks. DNA dependent ATP binding activity may then induce a conformational change that recruits other repair proteins to the site ( Figure 6A ). Such a model would predict that apart from FAAP24 other proteins might interact with FANCM. An unexpected finding reported here is the marked sensitivity to both UV light and camptothecin, interestingly this is a feature it shares with hamster cell line mutant of FANCG (26) . FANCM seems to utilize different domains to protect against the genotoxic effects of either of these agents, revealing a new level of complexity in the repair functions of this protein ( Figure 6B ). The helicase domain, but not its translocase activity (data not shown), is required to protect against UV light. However, it is not possible from our genetic studies to deduce how the FANCM helicase domain facilitates repair of UV light induced DNA damage, creating double mutants where FANCM disruption is combined with either NER or TLS genes may shed important light into this question. The marked sensitivity to camptothecin in the FANCM knockout requires the region emcompassing the nuclease domain. Camptothecin exerts its toxicity by covalently trapping type I topoisomerases-DNA complexes. Such complexes impede replication and are converted into lethal double strand breaks. The nuclease domain appears to have no obvious activity apart from binding to FAAP24 and HCLK2, and to fork structured DNA. Therefore, it could be that this FANCM domain can target repair enzymes to replication forks stalled at locked type I topoisomerases-DNA complexes. It is interesting to note that ÁBlm cells are also sensitive to CPT and it has been suggested that the Blm-Topo III complex helps resolve damage caused by this agent (27) . Since FANCM co-purifies with the Blm-Topo III complex (28) it is conceivable that the C terminus of FANCM recruits the Blm-Topo III complex to resolve such stalled forks.
FANCM loss in DT40 results in an increase in spontaneous SCE events. These events could reflect the presence of spontaneous DNA damage that is then resolved by HR. In such a scenario it is possible that replication fork breakage occurs more frequently in the absence of FANCM resulting in the accumulation of double strand breaks. Unrestrained homologous recombination may then repair such lesions and since some of such events are resolved by crossover this may result in raised SCE. Alternatively and more likely the SCE events could be due to a bias towards resolving recombination intermediates by crossover. How might FANCM act to suppress crossover recombination? Our studies clearly show that this requires the Walker DEAD box motif, and this is a distinct activity from the other FANCM based DNA damage tolerance responses reported here. In addition, our genetic studies show that FANCM functions in only a subset of Blm dependent non-crossover events. It is also noteworthy that both yeast FANCM orthologues-MPH1 and FML1 also suppress crossover recombination. However, in contrast to FANCM, both yeast FANCM orthologues function in an independent pathway to their respective Blm orthologues. Recombinant FANCM, Mph1 and Fml1 can all dissolve D loops ( Figure 6C ) (9, 10, 12) . These recombination intermediates precede crossover-resolving steps. By resolving such early recombination intermediates, FANCM may indirectly reduce crossover events. What might then be the function of Blm in such situations? One possibility is that FANCM synergises the function of Blm in dissolving D loops. The fact that Blm seems to be more important than FANCM in suppressing crossovers may reflect its key role in decatenating double Holliday junctions (18) . It will therefore be important to test whether Blm augments the antirecombinogenic biochemical activities of FANCM. Multiple DNA helicases in both budding yeast (Sgs1, Srs2, Mph1) (29, 30) and vertebrates (Blm, Wrn, Fbh1, FANCM, RecQL1, RecQL5) (31-33) defend their genomes from crossovers. The fact that mitotic eukaryotic cells display very low levels of crossovers is a testament to the evolutionary conserved function of these pathways. Their inactivation leaves genomes vulnerable to loss of heterozygosity, chromosome translocations and thereby to inevitable consequences on health.
